Vident Advisory »

Corcept Therapeutics Incorporated shares owned by Vident Advisory

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Vident Advisory from 13F filings

Historical chart of Vident Advisory investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Vident Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Vident Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 88k 32.48
2023-09-30 $2.4M 88k 27.25

More positions owned by Vident Advisory

Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Home Depot (HD)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Apple (AAPL)
Cisco Systems (CSCO)
Abbvie (ABBV)
Cameco Corporation (CCJ)
Etf Ser Solutions Vident Us Equity (VUSE)
Metropcs Communications (TMUS)
Applied Materials (AMAT)
Bristol Myers Squibb (BMY)
Comcast Corp Cl A (CMCSA)

View all positions for Vident Advisory

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Btim
Federated Investors
D. E. Shaw & Co
Susquehanna International
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Norges Bank Investment Management
Bank of New York Mellon
Millennium Management
Kynam Capital Management

View all funds holding Corcept Therapeutics Incorporated